ImmunXperts
ActiveSummary
ImmunXperts has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show negative equity (€-1.60M) and a net result of €-2.98M. Equity remains stable across the filed fiscal years (±1.3% per year). Its solvency ranks better than 10% of 243 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.5% (very low).
Checked score
Score 2024
31
/ 100
Weak
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability0▼-46
Solvency8▼-30
Growth32▼-20
Track record100
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.46 against 0.6 in 2023; short-term debt: 114.9% and cash: 15.8% of total assets), and equity is negative.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
-16.7%
Return on assets
-31.1%
Age of the figures
21 mo
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year €-1.60M
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 08-07-2025, 23 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
23 d early
2023
33 d early
2022
16 d late
2021
39 d early
2020
30 d late
2019
9 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-2.98M▼ 1,018%
2023 · €-266k
2018: €52k
2019: €10k
2020: €-4k
2021: €238k
2022: €458k
2023: €-266k
2018 → 2024
Working capital
€-5.99M▼ 58.7%
2023 · €-3.78M
2018: €668k
2019: €461k
2020: €569k
2021: €-430k
2022: €1.30M
2023: €-3.78M
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€1.45M-€1.45M▲ 0.3%€1.77M▲ 21.5%€1.40M▼ 20.5%€-1.60M
Operating result€-178k-€-34k▲ 80.8%€337k€-307k€-2.66M▼ 769%
Net result€-4k-€238k€458k▲ 92.6%€-266k€-2.98M▼ 1,018%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €2.66M in 2024 against €307k in 2023; the loss grows and 2024 has the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €9.58M
Fixed assets
€4.56M ▼ 12.4%
Current assets
€5.01M ▼ 10.9%
Key figures and ratios
EBITDA
€-1.78M▼
2023 · €254k
Cash flow
€-2.09M▼
2023 · €294k
Solvency
-16.7%▼
2023 · 12.9%
Current ratio
0.46▼
2023 · 0.60
Quick ratio
0.30▼
2023 · 0.42
Debt to equity
-6.98▼
2023 · 6.72
ROA
-31.1%▼
2023 · -2.5%
Interest coverage
-5.22▼
2023 · 3.66
Debt
€11.18M▲
2023 · €9.44M
Debt ≤ 1 year
€11.01M▲
2023 · €9.41M
Debt > 1 year
€2k▼
2023 · €32k
Income taxes
€3k▲
2023 · €927
Staff costs
€2.17M▼
2023 · €2.29M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 62 lines
Balance sheet
Code20232024
Assets
Total assets20/58€10.84M€9.58M▼
Fixed assets21/28€5.21M€4.56M▼
Intangible fixed assets21€129k€102k▼
Tangible fixed assets22/27€4.99M€4.37M▼
Plant, machinery and equipment23€1.33M€1.13M▼
Furniture and vehicles24€202k€135k▼
Leasing and similar rights25€61k€30k▼
Other tangible fixed assets26-€3.08M
Assets under construction and advance payments27€3.40M€0▼
Financial fixed assets28€98k€88k▼
Current assets29/58€5.63M€5.01M▼
Stocks and contracts in progress3€1.64M€1.75M▲
Stocks30/36€1.64M€1.75M▲
Amounts receivable within one year40/41€1.66M€1.47M▼
Trade receivables40€735k€1.16M▲
Other amounts receivable41€929k€304k▼
Cash at bank and in hand54/58€1.78M€1.51M▼
Deferred charges and accrued income490/1€537k€285k▼
Equity and liabilities
Total equity and liabilities10/49€10.84M€9.58M▼
Equity10/15€1.40M€-1.60M▼
Contributions10/11€831k€831k=
Capital10€831k€831k=
Issued capital100€831k€831k=
Reserves13€39k€39k=
Non-distributable reserves130/1€39k€39k=
Legal reserve130€39k€39k=
Profit (loss) carried forward14€462k€-2.51M▼
Investment grants15€73k€43k▼
Amounts payable17/49€9.44M€11.18M▲
Amounts payable after more than one year17€32k€2k▼
Financial debts170/4€32k€2k▼
Amounts payable within one year42/48€9.41M€11.01M▲
Current portion of amounts payable after more than one year42€41k€31k▼
Financial debts43-€1.11M
Credit institutions430/8-€1.11M
Trade debts44€1.35M€478k▼
Suppliers440/4€1.35M€478k▼
Taxes, remuneration and social security45€562k€628k▲
Remuneration and social security454/9€562k€628k▲
Other amounts payable47/48€7.45M€8.76M▲
Accrued charges and deferred income492/3€0€174k▲
Income statement
Code20232024
Non-recurring operating income76A€12k€0▼
Remuneration, social security and pensions62€2.29M€2.17M▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€560k€888k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€16k€-16k▼
Other operating charges640/8€1k€18k▲
Non-recurring operating charges66A€0-
Gross operating margin9900€2.56M€393k▼
Operating profit (loss)9901€-307k€-2.66M▼
Financial income75/76B€111k€30k▼
Recurring financial income75€111k€30k▼
Financial charges65/66B€69k€340k▲
Recurring financial charges65€69k€340k▲
Profit (loss) for the period before taxes9903€-265k€-2.97M▼
Income taxes67/77€927€3k▲
Profit (loss) for the period9904€-266k€-2.98M▼
Profit (loss) for the period to be appropriated9905€-266k€-2.98M▼
Appropriation of the result
Profit (loss) to be appropriated9906€462k€-2.51M▼
Profit (loss) brought forward from the previous period14P€728k€462k▼
Transfer to equity691/2€0-
To the legal reserve6920€0-
Social balance
Average headcount (FTE)908724.626.7▲
The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
08-01
State Gazette act
Appointment: Forvis Mazars Bedrijfsrevisoren - Forvis Mazars Réviseurs D'Entreprises (statutory auditor)2 facts ▸
State Gazette act
Appointment: Forvis Mazars Bedrijfsrevisoren - Forvis Mazars Réviseurs D'Entreprises (statutory auditor)
2 facts ▸
- Written decision, 16-10-2025
- Auditor appointment, Forvis Mazars Bedrijfsrevisoren - Forvis Mazars Réviseurs D'Entreprises (statutory auditor)
2025
08-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Weakest financial yearnet €-2.98M
Net result drops to €-2.98M, the lowest in the series.
28-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
02-02
State Gazette act
Registered officeRegistered-office move2 facts ▸
State Gazette act
Registered office
Registered-office move2 facts ▸
- Board meeting, 11-01-2024
- Registered-office move, Rue Clément Ader 10, 6041 Gosselies (Charleroi), Belgique
2023
16-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 16 days late
04-05
State Gazette act
Resignations & appointmentsPower of attorney · Mandate term7 facts ▸
State Gazette act
Resignations & appointments
Power of attorney · Mandate term7 facts ▸
- Board meeting, 15-03-2023
- Power of attorney, Kurt M Peeters
- Mandate term, jusqu'à la première des dates suivantes: (a) la date à laquelle le délégué cessera d'être employé au sein du groupe IQVIA (i.e., par la Société ou une de ses so…
- Mandate term, jusqu'à la première occurrence de (a) cinq (5) ans après la date de ces pouvoirs spéciaux ou (b) la révocation de ces pouvoirs spéciaux par le Conseil
- Mandate term, jusqu'à la première occurrence de (a) cinq (5) ans après la date de ces pouvoirs spéciaux ou (b) la révocation de ces pouvoirs spéciaux par le Conseil
- Mandate term, jusqu'à la première occurrence de (a) cinq (5) ans après la date de ces pouvoirs spéciaux ou (b) la révocation de ces pouvoirs spéciaux par le Conseil
- Mandate term, jusqu'à la première occurrence de (a) cinq (5) ans après la date de ces pouvoirs spéciaux ou (b) la révocation de ces pouvoirs spéciaux par le Conseil
14-02
State Gazette act
Resignation: Frank Swaelens (director)Appointment: Emmanuel Vanderhaegen (director) · Director discharge · Mandate compensation9 facts ▸
State Gazette act
Resignation: Frank Swaelens (director)
Appointment: Emmanuel Vanderhaegen (director) · Director discharge · Mandate compensation9 facts ▸
- General meeting, 01-02-2023
- Director resignation, Frank Swaelens (director)
- Director discharge, Frank Swaelens
- Director appointment, Emmanuel Vanderhaegen (director)
- Mandate compensation, Emmanuel Vanderhaegen
- Power of attorney, Jan-Frederik Keustermans
- Power of attorney, Kasper Theunissen
- Power of attorney, Michiel De Wolf
- Power of attorney, Talitha Crabbe
2022
31-12
Financial
Highest result since 2018net €458k ▲92.6%
Operating result €337k, net result €458k, both a record.
22-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
31-05
State Gazette act
Resignation: Nexelis Europe SRL (sole director)Appointments: Sofie Pattyn, Frank Swaelens and Clément Vanthournhout · Permanent representative: Benoit Bouche · Mandate compensation14 facts ▸
State Gazette act
Resignation: Nexelis Europe SRL (sole director)
Appointments: Sofie Pattyn, Frank Swaelens and Clément Vanthournhout · Permanent representative: Benoit Bouche · Mandate compensation14 facts ▸
- General meeting, 11-05-2022
- Director resignation, Nexelis Europe SRL (sole director)
- Director appointment, Sofie Pattyn (director)
- Mandate compensation, Sofie Pattyn
- Director appointment, Frank Swaelens (director)
- Mandate compensation, Frank Swaelens
- Director appointment, Clément Vanthournhout (director)
- Mandate compensation, Clément Vanthournhout
- Board meeting, 17-05-2022
- Power of attorney, Vahé Kalusyan
- Power of attorney, Ganbaru Consult SRL
- Director appointment, Sofie Pattyn (daily management delegate)
- +2 further facts in this act
2021
31-12
Financial
Back to profitnet €238k
Net result €238k after one loss-making year.
Show earlier events
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 30 days late
14-04
State Gazette act
Appointments: Ganbaru Consult SRL (daily management delegate) and Vahé Kalusyan (daily management delegate)Permanent representative: Sofie Pattyn · Mandate compensation · Power of attorney9 facts ▸
State Gazette act
Appointments: Ganbaru Consult SRL (daily management delegate) and Vahé Kalusyan (daily management delegate)
Permanent representative: Sofie Pattyn · Mandate compensation · Power of attorney9 facts ▸
- Board meeting, 20-10-2020
- Director appointment, Ganbaru Consult SRL (daily management delegate)
- Permanent representative, Sofie Pattyn
- Mandate compensation, Ganbaru Consult SRL
- Director appointment, Vahé Kalusyan (daily management delegate)
- Power of attorney, Vahé Kalusyan
- Mandate term, durée indéterminée
- Mandate limit, contrats et transactions jusqu'à 80.000 EUR maximum (items c, d, f, i, j); prime d'assurance annuelle 100.000 EUR maximum (item k); litiges et règlements amiabl…
- Mandate termination, Elle prend fin automatiquement dès que le mandataire cesse d'être un employé de la Société ou d'une société liée à la Société au sens de l'article 1:20 du Code…
2020
22-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
16-04
State Gazette act
Resignations: INVEST 4 IMMUNX, CTJ and 4 othersAppointment: Sardi Hoidings (sole director) · Permanent representative: Benoit Bouche · Statutes amendment18 facts ▸
State Gazette act
Resignations: INVEST 4 IMMUNX, CTJ and 4 others
Appointment: Sardi Hoidings (sole director) · Permanent representative: Benoit Bouche · Statutes amendment18 facts ▸
- General meeting, 19-03-2020
- Statutes amendment
- Capital, €830.878,94
- Director resignation, INVEST 4 IMMUNX (director)
- Director resignation, CTJ (director)
- Director resignation, BAM CONSULT (director)
- Director resignation, GANBARU (director)
- Director resignation, SAMBRINVEST (director)
- Director resignation, SAMBRINVEST SPIN OFF/SPIN-OUT (director)
- Director discharge, INVEST 4 IMMUNX
- Director discharge, CTJ
- Director discharge, BAM CONSULT
- +6 further facts in this act
26-03
State Gazette act
Capital & sharesCapital increase · Bank account · Capital5 facts ▸
State Gazette act
Capital & shares
Capital increase · Bank account · Capital5 facts ▸
- Board meeting, 03-03-2020
- Capital increase, €86.150,84
- Bank account, BE35 3631 9891 7637
- Capital, €830.878,94
- Statutes amendment
2019
24-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
23-01
State Gazette act
Capital & sharesShare issue · Capital increase · Power of attorney4 facts ▸
State Gazette act
Capital & shares
Share issue · Capital increase · Power of attorney4 facts ▸
- General meeting, 27-12-2018
- Share issue, 105062, warrants
- Capital increase
- Power of attorney, deux administrateurs agissant conjointement
2018
24-12
State Gazette act
Capital & sharesStatutes amendment1 fact ▸
State Gazette act
Capital & shares
Statutes amendment1 fact ▸
- Statutes amendment
10-07
State Gazette act
Reappointment: BAM Consult BVBA (director)Permanent representative: Philippe Stas · Resignation: BLA Consult BVBA (director)4 facts ▸
State Gazette act
Reappointment: BAM Consult BVBA (director)
Permanent representative: Philippe Stas · Resignation: BLA Consult BVBA (director)4 facts ▸
- General meeting, 05-06-2018
- Director reappointment, BAM Consult BVBA (director)
- Permanent representative, Philippe Stas
- Director resignation, BLA Consult BVBA (director)
20-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
13-10
State Gazette act
Permanent representative: Philippe JanssensPublication correction3 facts ▸
State Gazette act
Permanent representative: Philippe Janssens
Publication correction3 facts ▸
- General meeting, 05-06-2017
- Permanent representative, Philippe Janssens
- Publication correction, 31-10-2016
30-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
24-01
State Gazette act
Resignations: Anne Prignon, Micheline Streel and 2 othersAppointments: SAMBRINVEST, SAMBRINVEST SPIN-OFF/SPIN-OUT and 2 others · Permanent representatives: Anne Prignon, Micheline Streel and 2 others13 facts ▸
State Gazette act
Resignations: Anne Prignon, Micheline Streel and 2 others
Appointments: SAMBRINVEST, SAMBRINVEST SPIN-OFF/SPIN-OUT and 2 others · Permanent representatives: Anne Prignon, Micheline Streel and 2 others13 facts ▸
- General meeting, 04-01-2017
- Director resignation, Anne Prignon (director)
- Director resignation, Micheline Streel (director)
- Director resignation, Sofie Pattijn (director)
- Director resignation, Philippe Stas (director)
- Director appointment, SAMBRINVEST (director)
- Permanent representative, Anne Prignon
- Director appointment, SAMBRINVEST SPIN-OFF/SPIN-OUT (director)
- Permanent representative, Micheline Streel
- Director appointment, B.L.A. CONSULT (director)
- Permanent representative, Philippe Stas
- Director appointment, GANBARU CONSULT (director)
- +1 further facts in this act
2016
14-11
State Gazette act
Resignations: Arno KROMMINGA, Sofie PATTYN and 3 othersAppointments: Sofie PATTYN, Anne Germaine Prignon and 5 others · Permanent representative: Thibault Benoit Jonckheere · Statutes amendment18 facts ▸
State Gazette act
Resignations: Arno KROMMINGA, Sofie PATTYN and 3 others
Appointments: Sofie PATTYN, Anne Germaine Prignon and 5 others · Permanent representative: Thibault Benoit Jonckheere · Statutes amendment18 facts ▸
- General meeting, 04-08-2016
- Statutes amendment
- Capital decrease, €665.500
- Capital increase, €744.728,1
- Capital, €744.728,1
- Director resignation, Arno KROMMINGA (director)
- Director resignation, Sofie PATTYN (director)
- Director resignation, B.L.A. Consult (director)
- Director resignation, SAMBRINVEST SPIN OFF / SPIN-OUT (director)
- Director resignation, INVEST4IMMUNX (director)
- Director appointment, Sofie PATTYN (director)
- Director appointment, Anne Germaine Prignon (director)
- +6 further facts in this act
24-08
State Gazette act
Appointment: CTJ Consulting (managing director)Permanent representative: Thibault Jonckheere · Suspensive condition4 facts ▸
State Gazette act
Appointment: CTJ Consulting (managing director)
Permanent representative: Thibault Jonckheere · Suspensive condition4 facts ▸
- Board meeting, 01-08-2016
- Director appointment, CTJ Consulting (managing director)
- Permanent representative, Thibault Jonckheere
- Suspensive condition, sous condition suspensive de sa nomination en tant qu'administrateur de la Société par l'assemblée générale
28-06
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
2014
07-10
State Gazette act
Resignations: Sofie PATTYN, Armo KROMMINGA and B.L.A. CONSULT SPRLAppointments: Sofie PATTYN, Armo KROMMINGA and 3 others · Permanent representatives: Philippe STAS, Micheline STREEL and Philippus Maria Janssens de Varebeke · Capital increase22 facts ▸
State Gazette act
Resignations: Sofie PATTYN, Armo KROMMINGA and B.L.A. CONSULT SPRL
Appointments: Sofie PATTYN, Armo KROMMINGA and 3 others · Permanent representatives: Philippe STAS, Micheline STREEL and Philippus Maria Janssens de Varebeke · Capital increase22 facts ▸
- General meeting, 06-08-2014
- Capital increase, €151.000
- Capital increase, €453.000
- Capital, €665.500
- Statutes amendment
- Statutes amendment
- Director resignation, Sofie PATTYN (director)
- Director resignation, Armo KROMMINGA (director)
- Director resignation, B.L.A. CONSULT SPRL (director)
- Director appointment, Sofie PATTYN (director)
- Director appointment, Armo KROMMINGA (director)
- Director appointment, B.L.A. CONSULT SPRL (director)
- +10 further facts in this act
20-05
State Gazette act
IncorporationAppointments: Sofie PATTYN, Arno Jens KROMMINGA and B.L.A. Consult · Permanent representative: Philippe Paul STAS · Founding capital21 facts ▸
State Gazette act
Incorporation
Appointments: Sofie PATTYN, Arno Jens KROMMINGA and B.L.A. Consult · Permanent representative: Philippe Paul STAS · Founding capital21 facts ▸
- Incorporation, 15-05-2014
- Founding capital, €61.500
- Bank account, BNP PARIBAS FORTIS
- Founder, Sofie PATTYN
- Founder, Arno Jens KROMMINGA
- Founder, B.L.A. Consult
- Director appointment, Sofie PATTYN (director)
- Director appointment, Arno Jens KROMMINGA (director)
- Director appointment, B.L.A. Consult (director)
- Permanent representative, Philippe Paul STAS
- Mandate compensation, Sofie PATTYN
- Mandate compensation, Arno Jens KROMMINGA
- +9 further facts in this act
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
17 directors, no change since 2023
Emmanuel Vanderhaegen
CurrentDirector · since 01-02-2023
Clément Vanthournhout
CurrentDirector · since 11-05-2022
Sofie PATTYN
CurrentDaily management delegate · since 11-05-2022
Vahé Kalusyan
CurrentDaily management delegate · since 20-10-2020
Ganbaru Consult SRL
CurrentDaily management delegate · since 19-03-2020 · Legal entity · perm. rep.: Sofie Pattyn
Sardi Hoidings
Not recently confirmedSole director · since 19-03-2020 · Legal entity · perm. rep.: Benoit Bouche
11 other directors
BAM CONSULT
Not recently confirmedDirector · since 05-06-2018 · Private limited company · perm. rep.: Philippe Stas
BLACONSULT
Not recently confirmedDirector · since 15-05-2014 · Legal entity · perm. rep.: Philippe Paul STAS
Ganbaru Consult
Not recently confirmedDirector · since 04-01-2017 · Private limited company · perm. rep.: Sofie Pattijn
SAMBRINVEST SPIN-OFF/SPIN-OUT
Not recently confirmedDirector · since 04-01-2017 · Public limited company · perm. rep.: Micheline Streel
Société de Développement et de Participation du Bassin de Charleroi
Not recently confirmedDirector · since 04-01-2017 · Public limited company · perm. rep.: Anne Prignon
CTJ CONSULTING
Not recently confirmedDirector · since 01-08-2016 · Private limited company · perm. rep.: Thibault Jonckheere
Philippus JANSSENS de VAREBEKE
Not recently confirmedDirector · since 04-08-2016
Serge Louis Pampfer
Not recently confirmedObservateur du conseil d'administration · since 04-08-2016
Armo KROMMINGA
Not recently confirmedDirector · since 06-08-2014
B.L.A. CONSULT SPRL
Not recently confirmedDirector · since 06-08-2014 · Legal entity · perm. rep.: Philippe STAS
SAMBRINVEST SPIN OFF/SPIN-OUT SA
Not recently confirmedDirector · since 06-08-2014 · Legal entity · perm. rep.: Micheline STREEL
01-02-2023
Emmanuel Vanderhaegen: Appointed as Director
01-02-2023
Frank Swaelens: Resigned as Director
17-05-2022
Sofie PATTYN: Appointed as Daily management delegate
11-05-2022
Clément Vanthournhout: Appointed as Director
11-05-2022
Sofie PATTYN: Appointed as Director
Location & real-estate footprint
Registered office, Charleroi · 1 establishment unit since 2014
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Clément Ader 106041 CharleroiGround area
1.1 ha
Building footprint
1,056 m²
Volume, LiDAR
15,201 m³
2 parcels, Wallonia · tallest building 17.3 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
IMXP
since 20142.231.201.819
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52028B0295/02C000 | Wallonia | 7,830 m² | - | - |
| 52028B0295/00B002 | Wallonia | 3,131 m² | 1 · 1,056 m² | 17.2 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Statutory auditor
1 auditor| Forvis Mazars Réviseurs d’EntreprisesCurrent Statutory auditor | 30-12-2025 → present |
Articles of association
Purpose
Le développement et la fourniture de services d'analyse ou de prédiction d'effets secondaires des produits pharmaceutiques... [full object text]
Structure & network
Connections & network
26 connected companiesLinked via shared directors
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Show 22 more companies with a shared director
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Capital and shareholders
Shareholders according to the acts
At incorporation
act of 20-05-2014 ↗
- Sofie PATTYN founder
- Arno Jens KROMMINGA founder
- B.L.A. Consult (BE 0892.222.331) founder
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 16-04-2020 Capital stated in the act · 830,878.94 EUR · 1,272,414 shares
- 26-03-2020 Capital increase of 86,150.84 EUR · to 830,878.94 EUR · 105,062 new shares
- 14-11-2016 Capital reduction of 665,500 EUR · to 0 EUR · to absorb losses
- 14-11-2016 Capital increase of 744,728.10 EUR · to 744,728.10 EUR · 908,205 new shares
- 07-10-2014 Capital increase of 151,000 EUR · to 212,500 EUR · 184,146 new shares
- 07-10-2014 Capital increase of 453,000 EUR · to 665,500 EUR · from reserves
- 20-05-2014 Incorporation · 61,500 EUR · 75,000 shares
Public money · subsidies and aid
European research
1 project · 256,320 EUR EU contributionProgrammes
Horizon 2020
Projects
anti-Bacterial Innovative Vaccine Training Network.
Similar companies · same sector, comparable size
ConvEyXo
BE 0725.874.259
Charleroi · Eq €1,388,840
OLFADOG BIOTECH
BE 0794.892.333
Waterloo · Eq €1,442,474
DOCTEUR BOSQUART
BE 0885.419.760
Sint-Agatha-Berchem · Eq €1,449,034
E-Proteins
BE 0843.454.986
Gembloux · Eq €1,449,395
IPRATECH
BE 0893.778.586
Charleroi · Eq €1,455,788
Of 761 companies in sector 72101 we hold annual accounts for 481. 280 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded16-05-2014
Fiscal year end31-12
Abbreviation FR
IMXP
Activities, NACEBEL 2025
72101Research and development on biotechnology
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.